Lucid Diagnostics Inc. share price logo

Lucid Diagnostics Inc.

NASDAQ: LUCD

Small Cap

$1.08

+0.04

(+3.85%)

as on

Lucid Diagnostics Inc. Stock Performance

as on June 27, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.02
    $1.07
    downward going graph

    5.56%

    Downside

    -0.93%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.90
    $1.63
    downward going graph

    16.67%

    Downside

    50.86%

    Upside

    downward going graph

Lucid Diagnostics Inc. share price movements today

Previous Close
$1.04
Open
$1.03
Volume
1.7M
Day's Low - High
$1.02 - $1.07
52 Week Low - High
$0.90 - $1.63

Lucid Diagnostics Inc. Historical Returns

1 Month Return
-6.31 %
3 Month Return
-9.57 %
1 Year Return
-12.61 %
3 Year Return
-25.18 %
5 Year Return
0 %

Lucid Diagnostics Inc. Stock Fundamentals & Key Indicators

Check Lucid Diagnostics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$201.3M

EPS (TTM)

-0.2367

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-48.4M

Revenue (TTM)

5.1M

Profit Margin

0.00%

Return On Equity TTM

-710.60%

Lucid Diagnostics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lucid Diagnostics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Lucid Diagnostics Inc. image
Lucid Diagnostics Inc.
BUY$201.3MNANA0.00%NA
Stryker Corporation image
Stryker Corporation
BUY$120.3B20.19%36.3513.21%1.11%
Edwards Lifesciences Corp image
Edwards Lifesciences Corp
BUY$51.6B-13.37%46.9417.39%NA
Medtronic plc image
Medtronic plc
BUY$102.6B-35.55%21.4813.20%3.52%
Abbott Laboratories image
Abbott Laboratories
BUY$157.6B-17.28%25.3513.90%2.7%
See all

Stock Returns calculator for Lucid Diagnostics Inc. Stock including INR - Dollar returns

The Lucid Diagnostics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Lucid Diagnostics Inc. investment value today

Current value as on today

₹99,934

Returns

-₹66

(-0.07%)

Returns from Lucid Diagnostics Inc. Stock

-₹9,244 (-9.24%)

Dollar Impact

₹9,177 (+9.18%)

Analyst Recommendation on Lucid Diagnostics Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Lucid Diagnostics Inc.. Average target price of $3.95

Lucid Diagnostics Inc. Share Price Target

Get share price movements and forecasts by analysts on Lucid Diagnostics Inc..

What analysts predicted

72.66%UPSIDE

Target Price

$3.95

Current Price

$1.08

Analyzed by

12 Analysts

Target

$3.95

Lucid Diagnostics Inc. target price $3.95, a slight upside of 72.66% compared to current price of $1.08. According to 12 analysts rating.

Indian Investors' Interest in Lucid Diagnostics Inc. Stock

Search interest for Lucid Diagnostics Inc. Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-9% versus previous 30 day period

Lucid Diagnostics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1
1
0
1
1
0
1
1
1
1
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-11
-10
-11
-11
-12
-12
-11
-11
-14
-12
EBITDA
-10
-10
-10
-12
-11
-26
-4
-10
-16
-13
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-10
-11
-12
-11
-26
-4
-10
-16
-13
Income Tax Expense
-1,960
7,496
-
-12,358
7,496
9,110
3,449
-
-
9,719
Net Income
-10
-10
-11
-12
-11
-26
-4
-10
-16
-13
Net Profit Margin
-1041.35%
-1060.14%
-1127.56%
-1055.55%
-964.16%
-3249.76%
-381.69%
-858.55%
-1081.52%
-1107.40%

Lucid Diagnostics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
0
0
2
4
4
Gross Profit
-
-
0
-3
-6
-3
-2
Operating Income
-4
-8
-27
-56
-48
-46
-49
EBITDA
-4
-8
-27
-54
-49
-44
-57
Interest Expense
-
-
0
0
0
0
0
Depreciation
-
-
0
1
2
1
0
Income Before Tax
-4
-8
-28
-56
-52
-45
-58
Income Tax Expense
-4
-8
0
1
2
7,496
12,559
Net Income
-4
-8
-28
-56
-52
-45
-58
Net Profit Margin
0.00%
0.00%
-5615.60%
-14899.47%
-2169.11%
-1047.61%
-1232.68%

Lucid Diagnostics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-10
-11
-12
-11
-26
-4
-10
-26,652
-13
Operating Cash Flow
-12
-11
-10
-9
-12
-10
-10
-12
-12
Investing Cash Flow
0
-
0
0
0
0
0
0
0
Financing Cash Flow
18
11
0
17
15
16
27
0
5
Change in Cash
5
0
-10
7
2
5
16
-12
-6

Lucid Diagnostics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-8
-28
-56
-52
-45
-58
Operating Cash Flow
-2
-5
-17
-29
-32
-44
-46
Investing Cash Flow
0
0
0
-4
0
0
0
Financing Cash Flow
2
5
72
2
29
48
59
Change in Cash
0
0
53
-31
-3
3
12

Global Institutional Holdings in Lucid Diagnostics Inc.

Funds
Holdings
First Manhattan Co. LLC
0.17%
BMO Capital Markets Corp.
0.15%
Alyeska Investment Group, L.P.
0.72%
Aberdeen Group PLC
1.91%
Two Seas Capital LP
1.57%
See all

Insights on Lucid Diagnostics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, LUCD stock has moved up by 3.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -16.26M → -13.90M (in $), with an average increase of 17.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Stryker Corporation has given 0.7% return, outperforming this stock by 23.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 16.1% return, outperforming this stock by 23.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.50M → 1.25M (in $), with an average decrease of 16.5% per quarter

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
OrganisationLucid Diagnostics Inc.
Headquarters360 Madison Avenue, New York, NY, United States, 10017
IndustryMedical Devices
CEODr. Lishan Aklog M.D.
E-voting on sharesClick here to vote

Key Management of Lucid Diagnostics Inc.

Name

Title

Dr. Joseph Willis M.D.

Co-founder & Strategic Advisor

Dr. Amitabh Chak M.D.

Co-Founder & Strategic Advisor

Mr. Michael Adam Gordon

General Counsel & Secretary

Dr. Sanford D. Markowitz M.D., Ph.D.

Co-Founder & Strategic Advisor

Mr. Dennis M. McGrath CPA

Chief Financial Officer

Helen Moinova Ph.D.

Co-Founder & Strategic Advisor

Dr. Brian J. deGuzman M.D.

Chief Technology & Compliance Officer

Dr. Suman M. Verma M.D., Ph.D.

Senior VP & Chief Scientific Officer

Dr. Lishan Aklog M.D.

Chairman & CEO

Mr. Shaun M. O'Neill M.B.A.

President & COO

FAQs

What is Lucid Diagnostics Inc. share price today?

Lucid Diagnostics Inc. share price today is $1.08 as on at the close of the market. Lucid Diagnostics Inc. share today touched a day high of $1.07 and a low of $1.02.

What is the 52 week high and 52 week low for Lucid Diagnostics Inc. share?

Lucid Diagnostics Inc. share touched a 52 week high of $1.63 on and a 52 week low of $0.9 on . Lucid Diagnostics Inc. stock price today i.e. is closed at $1.08,which is 33.71% down from its 52 week high and 20.00% up from its 52 week low.

What is Lucid Diagnostics Inc.'s market capitalisation today?

Lucid Diagnostics Inc. market capitalisation is $0.00T as on .

How to invest in Lucid Diagnostics Inc. Stock (LUCD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lucid Diagnostics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lucid Diagnostics Inc. Shares that will get you 1.3889 shares as per Lucid Diagnostics Inc. share price of $1.08 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy Lucid Diagnostics Inc. Stock (LUCD) from India?

Indian investors can start investing in Lucid Diagnostics Inc. (LUCD) shares with as little as ₹94.3 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Lucid Diagnostics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Lucid Diagnostics Inc. share’s latest price of $1.08 as on June 27, 2026 at 8:46 am IST, you will get 9.2593 shares of Lucid Diagnostics Inc.. Learn more about fractional shares .